MedTrace Logo

Paracetamol Plus Tramadol Versus Fentanyl As Preemptive Analgesia For Enhanced Recovery After Day Case Surgeries

NCT06561672 · Status: ENROLLING_BY_INVITATION · Phase: EARLY_PHASE1 · Type: INTERVENTIONAL · Enrollment: 102

Last updated 2024-08-20

No results posted yet for this study

Summary

Implementation of enhanced recovery in day case surgeries using either preemptive intravenous paracetamol plus tramadol or preemptive intravenous fentanyl.

Conditions

  • Preemptive Paracetamol Plus Tramadol and Preemptive Fentanyl

Interventions

DRUG

tramadol plus paracetamol

Intravenous infusion of 15mg/kg paracetamol together with 1mg/kg tramadol will be started and to be finished before starting of induction of anesthesia (induction agent will be propofol 2mg/kg and muscle relaxant (cisatracurium) 0.15 mg/kg)

DRUG

Fentanyl

Intravenous injection of 1.5 microgram/kg fentanyl will be given to the patient followed by induction agents (propofol 2mg/kg).

DRUG

propofol and muscle relaxant (cisatracurium)

propofol 2mg/kg and muscle relaxant (cisatracurium) 0.15 mg/kg)

DRUG

Propofol

propofol 2mg/kg

Sponsors & Collaborators

  • Zagazig University

    lead OTHER_GOV

Principal Investigators

  • marwa M Medhat, MD · Zagazig University

Study Design

Allocation
RANDOMIZED
Purpose
TREATMENT
Masking
DOUBLE
Model
PARALLEL

Eligibility

Min Age
21 Years
Max Age
65 Years
Sex
ALL
Healthy Volunteers
No

Timeline & Regulatory

Start
2024-09-01
Primary Completion
2025-03-20
Completion
2025-06-20

Countries

  • Egypt

Study Locations

More Related Trials

Entities

Drugs

Read the full study record

This page highlights key information. For complete eligibility criteria, study locations, investigator contacts, and the full protocol, visit the original record on ClinicalTrials.gov.

View NCT06561672 on ClinicalTrials.gov